Why is Metropolis Healt falling/rising?

As of 09-Jul, Metropolis Healthcare Ltd's stock price is rising, currently at 2,058.30, reflecting an increase of 192.3 or 10.31%. The stock has shown strong performance recently, with a consecutive gain over the last 8 days, resulting in a total return of 22.5% during this period. It has outperformed its sector by 10.66% today and has traded at an intraday high of Rs 2105.55. Additionally, the stock has been trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bullish trend. Positive factors contributing to this rise include high management efficiency with a return on capital employed (ROCE) of 26.87%, a low debt-to-equity ratio, and significant institutional holdings at 45.58%, which suggest confidence from knowledgeable investors. However, the company faces challenges such as poor long-term growth metrics, with net sales and operating profit growth lagging, and negative quarterly results indicating a decline in profitability.
In the broader market context, Metropolis Healthcare's short-term performance has significantly outpaced the benchmark Sensex, which has only increased by 0.15% over the past week, while Metropolis has surged by 19.24%. This stark contrast highlights the stock's strong momentum relative to the market. Despite its recent gains, the company has a year-to-date return of -0.24%, underperforming the Sensex's 6.91% increase, indicating that while the stock is currently on an upward trajectory, it has struggled to maintain consistent growth over a longer period. The high valuation metrics, such as a price-to-book ratio of 8 and a PEG ratio of 6.1, suggest that the stock may be considered expensive relative to its earnings growth, which could pose risks for future performance.